Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist.
Muzio M
J Exp Med. 182(2):623-8.
Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
Colotta F
J Exp Med. 181(6):2181-6.
Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface “receptor” with anti-interleukin-1 function.
Re F
J Exp Med. 183(4):1841-50.
Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes.
Sica A
J Exp Med. 185(5):969-74.
Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells.
Godiska R
J Exp Med. 185(9):1595-604.
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.
Romano M
Immunity. 6(3):315-25.
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.
Bonecchi R
J Exp Med. 187(1):129-34.
Interleukin 10 increases CCR5 expression and HIV infection in human monocytes.
Sozzani S
J Exp Med. 187(3):439-44.
The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6).
Muzio M
J Exp Med. 187(12):2097-101.
Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.
Hirsch E
Science. 287(5455):1049-53.